3R tau expression modifies behavior in transgenic mice

Journal of Neuroscience Research

Volumn 88, Issue 12, 2010, Pages 2727-2735

  Shiryaev, Natalia ^a   Jouroukhin, Yan ^a   Gozes, Illana ^a,b  

^a Department of Clinical Biochemistry ^*

^b Adams Super Center for Brain Studies   (United States)

Author keywords

Learning and memory; Open field test (OFT); Passive avoidance test (PAT); Tau hypophosphorylation; Tau transgenic model; Three repeat tau

Indexed keywords

TAU PROTEIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; AVOIDANCE BEHAVIOR; BRAIN; BRAIN CORTEX; BRAIN REGION; CONTROLLED STUDY; GENE MUTATION; GENE OVEREXPRESSION; LEARNING; LOCOMOTION; MALE; MAZE TEST; MEMORY; MOUSE; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TASK PERFORMANCE; TRANSGENIC MOUSE;

ANIMALS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; CEREBRAL CORTEX; FEMALE; GENE EXPRESSION REGULATION; HUMANS; LEARNING DISORDERS; MALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MOLECULAR WEIGHT; PHOSPHORYLATION; PROTEIN ISOFORMS; TAU PROTEINS; TAUOPATHIES;

EID: 77955476100     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22431     Document Type: Article

References (24)

1. Best PJ, Orr J Jr. 1973. Effects of hippocampal lesions on passive avoidance and taste aversion conditioning. Physiol Behav 10:193-196.
2. Biernat J, Mandelkow EM. 1999. The development of cell processes induced by tau protein requires phosphorylation of serine 262 and 356 in the repeat domain and is inhibited by phosphorylation in the proline-rich domains. Mol Biol Cell 10:727-740. (Pubitemid 29144634)
3. Boekhoorn K, Terwel D, Biemans B, Borghgraef P, Wiegert O, Ramakers GJ, de Vos K, Krugers H, Tomiyama T, Mori H, Joels M, van Leuven F, Lucassen PJ. 2006. Improved long-term potentiation and memory in young tau-P301L transgenic mice before onset of hyperphosphorylation and tauopathy. J Neurosci 26:3514-3523.
4. Caffrey TM, Joachim C, Paracchini S, Esiri MM, Wade-Martins R. 2006. Haplotype-specific expression of exon 10 at the human MAPT locus. Hum Mol Genet 15:3529-3537.
5. Crawley JN. 2006. What's wrong with my mouse? Behavioral phenotyping of transgenic and knockout mice. New York: Wiley.
6. De Leonibus E, Costantini VJ, Castellano C, Ferretti V, Oliverio A, Mele A. 2003. Distinct roles of the different ionotropic glutamate receptors within the nucleus accumbens in passive-avoidance learning and memory in mice. Eur J Neurosci 18:2365-2373.
7. Duff K, Knight H, Refolo LM, Sanders S, Yu X, Picciano M, Malester B, Hutton M, Adamson J, Goedert M, Burki K, Davies P. 2000. Characterization of pathology in transgenic mice over-expressing human genomic and cDNA tau transgenes. Neurobiol Dis 7:87-98.
8. Goedert M, Spillantini MG, Jakes R, Rutherford D, Crowther RA. 1989. Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 3:519-526.
9. Gordon I, Grauer E, Genis I, Sehayek E, Michaelson DM. 1995. Memory deficits and cholinergic impairments in apolipoprotein E-deficient mice. Neurosci Lett 199:1-4.
10. Gozes I, Giladi E, Pinhasov A, Bardea A, Brenneman DE. 2000. Activity-dependent neurotrophic factor: intranasal administration of femtomolar-acting peptides improve performance in a water maze. J Pharmacol Exp Ther 293:1091-1098. (Pubitemid 30417880)
11. Ishihara T, Hong M, Zhang B, Nakagawa Y, Lee MK, Trojanowski JQ, Lee VM. 1999. Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform. Neuron 24:751-762.
12. Ishihara T, Zhang B, Higuchi M, Yoshiyama Y, Trojanowski JQ, Lee VM. 2001. Age-dependent induction of congophilic neurofibrillary tau inclusions in tau transgenic mice. Am J Pathol 158:555-562.
13. Kosaka S, Takuma H, Tomiyama T, Mori H. 2004. The distributions of tau short and long isoforms fused with EGFP in cultured cells. Osaka City Med J 50:19-27.
14. Lewis J, McGowan E, Rockwood J, Melrose H, Nacharaju P, Van Slegtenhorst M, Gwinn-Hardy K, Paul Murphy M, Baker M, Yu X, Duff K, Hardy J, Corral A, Lin WL, Yen SH, Dickson DW, Davies P, Hutton M. 2000. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat Genet 25:402-405.
15. Matsuoka Y, Jouroukhin Y, Gray AJ, Ma L, Hirata-Fukae C, Li HF, Feng L, Lecanu L, Walker BR, Planel E, Arancio O, Gozes I, Aisen PS. 2008. A neuronal microtubule-interacting agent, NAPVSIPQ, reduces tau pathology and enhances cognitive function in a mouse model of Alzheimer's disease. J Pharmacol Exp Ther 325:146-153.
16. Myers AJ, Pittman AM, Zhao AS, Rohrer K, Kaleem M, Marlowe L, Lees A, Leung D, McKeith IG, Perry RH, Morris CM, Trojanowski JQ, Clark C, Karlawish J, Arnold S, Forman MS, Van Deerlin V, de Silva R, Hardy J. 2007. The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts. Neurobiol Dis 25:561-570.
17. Power AE, Thal LJ, McGaugh JL. 2002. Lesions of the nucleus basalis magnocellularis induced by 192 IgG-saporin block memory enhancement with posttraining norepinephrine in the basolateral amygdala. Proc Natl Acad Sci U S A 99:2315-2319.
18. Ramsden M, Kotilinek L, Forster C, Paulson J, McGowan E, SantaCruz K, Guimaraes A, Yue M, Lewis J, Carlson G, Hutton M, Ashe KH. 2005. Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L). J Neurosci 25:10637-10647.
19. Santacruz K, Lewis J, Spires T, Paulson J, Kotilinek L, Ingelsson M, Guimaraes A, DeTure M, Ramsden M, McGowan E, Forster C, Yue M, Orne J, Janus C, Mariash A, Kuskowski M, Hyman B, Hutton M, Ashe KH. 2005. Tau suppression in a neurodegenerative mouse model improves memory function. Science 309:476-481.
20. Seeley WW, Matthews BR, Crawford RK, Gorno-Tempini ML, Foti D, Mackenzie IR, Miller BL. 2008. Unravelling Bolero: progressive aphasia, transmodal creativity and the right posterior neocortex. Brain 131:39-49.
21. Takuma H, Arawaka S, Mori H. 2003. Isoforms changes of tau protein during development in various species. Brain Res Dev Brain Res 142:121-127. (Pubitemid 36593156)
22. Tanemura K, Murayama M, Akagi T, Hashikawa T, Tominaga T, Ichikawa M, Yamaguchi H, Takashima A. 2002. Neurodegeneration with tau accumulation in a transgenic mouse expressing V337M human tau. J Neurosci 22:133-141.
23. Wolfer DP, Lipp HP. 2000. Dissecting the behaviour of transgenic mice: is it the mutation, the genetic background, or the environment? Exp Physiol 85:627-634.
24. Yu JZ, Kuret J, Rasenick MM. 2002. Transient expression of fluorescent tau proteins promotes process formation in PC12 cells: contributions of the tau C-terminus to this process. J Neurosci Res 67:625-633.